nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorzoxazone—CYP1A1—chronic obstructive pulmonary disease	0.237	0.509	CbGaD
Chlorzoxazone—CYP1A2—chronic obstructive pulmonary disease	0.229	0.491	CbGaD
Chlorzoxazone—CYP2A6—Arformoterol—chronic obstructive pulmonary disease	0.0742	0.169	CbGbCtD
Chlorzoxazone—CYP2A6—Formoterol—chronic obstructive pulmonary disease	0.0742	0.169	CbGbCtD
Chlorzoxazone—CYP2A6—Montelukast—chronic obstructive pulmonary disease	0.0562	0.128	CbGbCtD
Chlorzoxazone—CYP2E1—Aminophylline—chronic obstructive pulmonary disease	0.0416	0.0946	CbGbCtD
Chlorzoxazone—CYP2A6—Prednisolone—chronic obstructive pulmonary disease	0.033	0.075	CbGbCtD
Chlorzoxazone—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0241	0.0547	CbGbCtD
Chlorzoxazone—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0233	0.053	CbGbCtD
Chlorzoxazone—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0233	0.053	CbGbCtD
Chlorzoxazone—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0208	0.0472	CbGbCtD
Chlorzoxazone—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0196	0.0445	CbGbCtD
Chlorzoxazone—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0132	0.03	CbGbCtD
Chlorzoxazone—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0126	0.0287	CbGbCtD
Chlorzoxazone—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0112	0.0255	CbGbCtD
Chlorzoxazone—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0066	0.015	CbGbCtD
Chlorzoxazone—KCNMA1—pulmonary artery—chronic obstructive pulmonary disease	0.00628	0.575	CbGeAlD
Chlorzoxazone—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00623	0.0142	CbGbCtD
Chlorzoxazone—Lightheadedness—Aminophylline—chronic obstructive pulmonary disease	0.00142	0.0368	CcSEcCtD
Chlorzoxazone—Lightheadedness—Salbutamol—chronic obstructive pulmonary disease	0.00102	0.0264	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Roflumilast—chronic obstructive pulmonary disease	0.000968	0.025	CcSEcCtD
Chlorzoxazone—Angioedema—Roflumilast—chronic obstructive pulmonary disease	0.000954	0.0246	CcSEcCtD
Chlorzoxazone—Malaise—Roflumilast—chronic obstructive pulmonary disease	0.000941	0.0243	CcSEcCtD
Chlorzoxazone—Discomfort—Roflumilast—chronic obstructive pulmonary disease	0.000878	0.0226	CcSEcCtD
Chlorzoxazone—KCNMA1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000851	0.0779	CbGeAlD
Chlorzoxazone—Petechiae—Prednisolone—chronic obstructive pulmonary disease	0.000798	0.0206	CcSEcCtD
Chlorzoxazone—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.00075	0.0193	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.000735	0.019	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.000702	0.0181	CcSEcCtD
Chlorzoxazone—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.000664	0.0171	CcSEcCtD
Chlorzoxazone—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.00064	0.0165	CcSEcCtD
Chlorzoxazone—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.0006	0.0155	CcSEcCtD
Chlorzoxazone—Ecchymosis—Prednisolone—chronic obstructive pulmonary disease	0.000593	0.0153	CcSEcCtD
Chlorzoxazone—Petechiae—Prednisone—chronic obstructive pulmonary disease	0.00058	0.015	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.000568	0.0147	CcSEcCtD
Chlorzoxazone—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000563	0.0145	CcSEcCtD
Chlorzoxazone—KCNMA1—lung—chronic obstructive pulmonary disease	0.000561	0.0514	CbGeAlD
Chlorzoxazone—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000537	0.0139	CcSEcCtD
Chlorzoxazone—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000537	0.0138	CcSEcCtD
Chlorzoxazone—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.0005	0.0129	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.000491	0.0127	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.000491	0.0127	CcSEcCtD
Chlorzoxazone—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000484	0.0125	CcSEcCtD
Chlorzoxazone—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000484	0.0125	CcSEcCtD
Chlorzoxazone—Malaise—Formoterol—chronic obstructive pulmonary disease	0.000478	0.0123	CcSEcCtD
Chlorzoxazone—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.000478	0.0123	CcSEcCtD
Chlorzoxazone—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000474	0.0122	CcSEcCtD
Chlorzoxazone—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000471	0.0122	CcSEcCtD
Chlorzoxazone—CYP2A6—lung—chronic obstructive pulmonary disease	0.000468	0.0429	CbGeAlD
Chlorzoxazone—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000464	0.012	CcSEcCtD
Chlorzoxazone—CYP1A2—respiratory system—chronic obstructive pulmonary disease	0.000463	0.0424	CbGeAlD
Chlorzoxazone—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000462	0.0119	CcSEcCtD
Chlorzoxazone—CYP1A1—respiratory system—chronic obstructive pulmonary disease	0.000457	0.0419	CbGeAlD
Chlorzoxazone—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000457	0.0118	CcSEcCtD
Chlorzoxazone—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000451	0.0116	CcSEcCtD
Chlorzoxazone—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000446	0.0115	CcSEcCtD
Chlorzoxazone—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000446	0.0115	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000432	0.0112	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000432	0.0112	CcSEcCtD
Chlorzoxazone—Ecchymosis—Prednisone—chronic obstructive pulmonary disease	0.000431	0.0111	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000423	0.0109	CcSEcCtD
Chlorzoxazone—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000421	0.0109	CcSEcCtD
Chlorzoxazone—CYP2E1—respiratory system—chronic obstructive pulmonary disease	0.000417	0.0382	CbGeAlD
Chlorzoxazone—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000408	0.0105	CcSEcCtD
Chlorzoxazone—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000384	0.00992	CcSEcCtD
Chlorzoxazone—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000384	0.00992	CcSEcCtD
Chlorzoxazone—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000381	0.00982	CcSEcCtD
Chlorzoxazone—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000381	0.00982	CcSEcCtD
Chlorzoxazone—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000376	0.00971	CcSEcCtD
Chlorzoxazone—CYP1A1—bronchus—chronic obstructive pulmonary disease	0.000376	0.0345	CbGeAlD
Chlorzoxazone—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000376	0.00969	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000373	0.00963	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000373	0.00963	CcSEcCtD
Chlorzoxazone—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000373	0.00962	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000366	0.00943	CcSEcCtD
Chlorzoxazone—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000363	0.00936	CcSEcCtD
Chlorzoxazone—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000359	0.00927	CcSEcCtD
Chlorzoxazone—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000358	0.00924	CcSEcCtD
Chlorzoxazone—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000358	0.00923	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000356	0.00919	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000356	0.00919	CcSEcCtD
Chlorzoxazone—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000354	0.00914	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000352	0.00909	CcSEcCtD
Chlorzoxazone—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000346	0.00893	CcSEcCtD
Chlorzoxazone—CYP1A1—trachea—chronic obstructive pulmonary disease	0.000338	0.0309	CbGeAlD
Chlorzoxazone—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000338	0.00871	CcSEcCtD
Chlorzoxazone—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000337	0.00871	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000336	0.00868	CcSEcCtD
Chlorzoxazone—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000286	0.00738	CcSEcCtD
Chlorzoxazone—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000286	0.00738	CcSEcCtD
Chlorzoxazone—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00028	0.00722	CcSEcCtD
Chlorzoxazone—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000273	0.00703	CcSEcCtD
Chlorzoxazone—Rash—Formoterol—chronic obstructive pulmonary disease	0.000273	0.00703	CcSEcCtD
Chlorzoxazone—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000272	0.00703	CcSEcCtD
Chlorzoxazone—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000272	0.00703	CcSEcCtD
Chlorzoxazone—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00027	0.00696	CcSEcCtD
Chlorzoxazone—Rash—Montelukast—chronic obstructive pulmonary disease	0.000267	0.00689	CcSEcCtD
Chlorzoxazone—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000267	0.00688	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000266	0.00687	CcSEcCtD
Chlorzoxazone—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000262	0.00676	CcSEcCtD
Chlorzoxazone—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000259	0.00667	CcSEcCtD
Chlorzoxazone—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000257	0.00664	CcSEcCtD
Chlorzoxazone—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000257	0.00663	CcSEcCtD
Chlorzoxazone—CYP1A2—lung—chronic obstructive pulmonary disease	0.000246	0.0225	CbGeAlD
Chlorzoxazone—CYP1A1—lung—chronic obstructive pulmonary disease	0.000243	0.0222	CbGeAlD
Chlorzoxazone—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000241	0.00623	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000234	0.00604	CcSEcCtD
Chlorzoxazone—CYP2E1—lung—chronic obstructive pulmonary disease	0.000221	0.0203	CbGeAlD
Chlorzoxazone—CYP1A1—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000202	0.00455	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000202	0.00454	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000198	0.00446	CbGpPWpGaD
Chlorzoxazone—CYP2A6—NRF2 pathway—SOD3—chronic obstructive pulmonary disease	0.000196	0.00442	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000193	0.00436	CbGpPWpGaD
Chlorzoxazone—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000193	0.00499	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000193	0.00498	CcSEcCtD
Chlorzoxazone—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.00019	0.00491	CcSEcCtD
Chlorzoxazone—CYP1A1—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000189	0.00425	CbGpPWpGaD
Chlorzoxazone—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000188	0.00485	CcSEcCtD
Chlorzoxazone—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000186	0.00419	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000182	0.0041	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000178	0.004	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000177	0.00399	CbGpPWpGaD
Chlorzoxazone—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000175	0.00452	CcSEcCtD
Chlorzoxazone—CYP1A2—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000175	0.00394	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000173	0.0039	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000171	0.00385	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.00017	0.00384	CbGpPWpGaD
Chlorzoxazone—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.00017	0.00439	CcSEcCtD
Chlorzoxazone—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000168	0.00378	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000167	0.00376	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000163	0.00368	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000161	0.00363	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000161	0.00363	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.00016	0.0036	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000159	0.00358	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000157	0.00354	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000156	0.0035	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Circadian rythm related genes—LEP—chronic obstructive pulmonary disease	0.000156	0.0035	CbGpPWpGaD
Chlorzoxazone—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000155	0.00399	CcSEcCtD
Chlorzoxazone—KCNMA1—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	0.000153	0.00345	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	0.000153	0.00345	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000153	0.00344	CbGpPWpGaD
Chlorzoxazone—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.00015	0.00386	CcSEcCtD
Chlorzoxazone—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000148	0.00381	CcSEcCtD
Chlorzoxazone—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000147	0.0038	CcSEcCtD
Chlorzoxazone—KCNMA1—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	0.000145	0.00326	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000144	0.00325	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000141	0.00316	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.00014	0.00316	CbGpPWpGaD
Chlorzoxazone—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.00014	0.00362	CcSEcCtD
Chlorzoxazone—CYP2A6—NRF2 pathway—SERPINA1—chronic obstructive pulmonary disease	0.00014	0.00315	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000135	0.00305	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000135	0.00304	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Hemostasis—TGFB2—chronic obstructive pulmonary disease	0.000133	0.00299	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000132	0.00298	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000129	0.00291	CbGpPWpGaD
Chlorzoxazone—CYP2A6—NRF2 pathway—GCLC—chronic obstructive pulmonary disease	0.000128	0.00288	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000127	0.00285	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000126	0.00283	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000126	0.00283	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000124	0.0028	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000123	0.00277	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	0.000122	0.00275	CbGpPWpGaD
Chlorzoxazone—CYP2A6—NRF2 pathway—TGFB2—chronic obstructive pulmonary disease	0.000121	0.00273	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000121	0.00273	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Hemostasis—HDAC2—chronic obstructive pulmonary disease	0.000119	0.00268	CbGpPWpGaD
Chlorzoxazone—CYP2A6—NRF2 pathway—SLC6A4—chronic obstructive pulmonary disease	0.000119	0.00268	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000114	0.00256	CbGpPWpGaD
Chlorzoxazone—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000112	0.0029	CcSEcCtD
Chlorzoxazone—CYP2A6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000112	0.00253	CbGpPWpGaD
Chlorzoxazone—CYP1A1—PPARA activates gene expression—CTGF—chronic obstructive pulmonary disease	0.000109	0.00246	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Hemostasis—PLAUR—chronic obstructive pulmonary disease	0.000107	0.00242	CbGpPWpGaD
Chlorzoxazone—Rash—Prednisone—chronic obstructive pulmonary disease	0.000107	0.00277	CcSEcCtD
Chlorzoxazone—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000107	0.00276	CcSEcCtD
Chlorzoxazone—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—chronic obstructive pulmonary disease	0.000107	0.0024	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000106	0.0024	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000102	0.0023	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	9.96e-05	0.00224	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	9.94e-05	0.00224	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	9.43e-05	0.00212	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	9.35e-05	0.00211	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	9.35e-05	0.00211	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	9.35e-05	0.00211	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	9.22e-05	0.00208	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	9.11e-05	0.00205	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Fluoropyrimidine Activity—TP53—chronic obstructive pulmonary disease	9.09e-05	0.00205	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	8.97e-05	0.00202	CbGpPWpGaD
Chlorzoxazone—CYP2A6—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	8.97e-05	0.00202	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	8.93e-05	0.00201	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	8.87e-05	0.002	CbGpPWpGaD
Chlorzoxazone—CYP2A6—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	8.85e-05	0.00199	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	8.81e-05	0.00198	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	8.75e-05	0.00197	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	8.46e-05	0.0019	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	8.36e-05	0.00188	CbGpPWpGaD
Chlorzoxazone—CYP2A6—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	8.24e-05	0.00186	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	8.22e-05	0.00185	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	8.12e-05	0.00183	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	8.03e-05	0.00181	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	7.93e-05	0.00178	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.87e-05	0.00177	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Hemostasis—MMP1—chronic obstructive pulmonary disease	7.68e-05	0.00173	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	7.56e-05	0.0017	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Hemostasis—PLAU—chronic obstructive pulmonary disease	7.54e-05	0.0017	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	7.46e-05	0.00168	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	7.46e-05	0.00168	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—chronic obstructive pulmonary disease	7.36e-05	0.00166	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	7.35e-05	0.00166	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	7.24e-05	0.00163	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.23e-05	0.00163	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	7.22e-05	0.00163	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	7.03e-05	0.00158	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.93e-05	0.00156	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Hemostasis—NOS2—chronic obstructive pulmonary disease	6.93e-05	0.00156	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	6.87e-05	0.00155	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.86e-05	0.00154	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	6.51e-05	0.00147	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	6.39e-05	0.00144	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	6.37e-05	0.00143	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	6.34e-05	0.00143	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	6.31e-05	0.00142	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	6.29e-05	0.00142	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.22e-05	0.0014	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	6.18e-05	0.00139	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	6.18e-05	0.00139	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.13e-05	0.00138	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	6.13e-05	0.00138	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	5.95e-05	0.00134	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	5.89e-05	0.00133	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	5.89e-05	0.00133	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	5.87e-05	0.00132	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.86e-05	0.00132	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	5.84e-05	0.00131	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	5.83e-05	0.00131	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Hemostasis—ALB—chronic obstructive pulmonary disease	5.82e-05	0.00131	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	5.81e-05	0.00131	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.78e-05	0.0013	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	5.76e-05	0.0013	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.71e-05	0.00129	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.64e-05	0.00127	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Hemostasis—NOS3—chronic obstructive pulmonary disease	5.57e-05	0.00125	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—APIP—chronic obstructive pulmonary disease	5.52e-05	0.00124	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.42e-05	0.00122	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.39e-05	0.00121	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.39e-05	0.00121	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.34e-05	0.0012	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.33e-05	0.0012	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.31e-05	0.0012	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.29e-05	0.00119	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.22e-05	0.00117	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	5.18e-05	0.00117	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	4.73e-05	0.00107	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.41e-05	0.000993	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	4.38e-05	0.000986	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—APIP—chronic obstructive pulmonary disease	4.36e-05	0.000981	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.35e-05	0.00098	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	4.16e-05	0.000937	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	4.11e-05	0.000926	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—APIP—chronic obstructive pulmonary disease	4.11e-05	0.000925	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.06e-05	0.000913	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	4.02e-05	0.000905	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Hemostasis—VEGFA—chronic obstructive pulmonary disease	4.01e-05	0.000903	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4e-05	0.0009	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	3.94e-05	0.000888	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	3.94e-05	0.000888	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.84e-05	0.000865	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.79e-05	0.000854	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	3.79e-05	0.000853	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	3.76e-05	0.000845	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	3.76e-05	0.000845	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.74e-05	0.000842	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.69e-05	0.00083	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Hemostasis—TGFB1—chronic obstructive pulmonary disease	3.68e-05	0.000829	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.65e-05	0.000822	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—GC—chronic obstructive pulmonary disease	3.55e-05	0.0008	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.46e-05	0.000779	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.44e-05	0.000773	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.41e-05	0.000768	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.39e-05	0.000763	CbGpPWpGaD
Chlorzoxazone—CYP2A6—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	3.36e-05	0.000757	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.3e-05	0.000744	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.26e-05	0.000733	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.21e-05	0.000723	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	3.09e-05	0.000696	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Hemostasis—TP53—chronic obstructive pulmonary disease	3.03e-05	0.000682	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.93e-05	0.00066	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.89e-05	0.00065	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.89e-05	0.00065	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.85e-05	0.000641	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—GC—chronic obstructive pulmonary disease	2.81e-05	0.000632	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.72e-05	0.000613	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.7e-05	0.000608	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.65e-05	0.000597	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—GC—chronic obstructive pulmonary disease	2.65e-05	0.000596	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	2.62e-05	0.00059	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.61e-05	0.000589	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.61e-05	0.000588	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.51e-05	0.000566	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.48e-05	0.000558	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.46e-05	0.000554	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.05e-05	0.000461	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	2.02e-05	0.000455	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	1.99e-05	0.000449	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.94e-05	0.000437	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.92e-05	0.000432	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.87e-05	0.000421	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.85e-05	0.000417	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.75e-05	0.000394	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.74e-05	0.000391	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.69e-05	0.00038	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.61e-05	0.000363	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.57e-05	0.000353	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.53e-05	0.000345	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.52e-05	0.000341	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.45e-05	0.000326	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.43e-05	0.000322	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.38e-05	0.000312	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.35e-05	0.000303	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.34e-05	0.000302	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.33e-05	0.0003	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.33e-05	0.000299	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.3e-05	0.000294	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.3e-05	0.000293	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.28e-05	0.000287	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.25e-05	0.000282	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.24e-05	0.000278	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.21e-05	0.000273	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.2e-05	0.000271	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.17e-05	0.000264	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.09e-05	0.000245	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.08e-05	0.000242	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.06e-05	0.000239	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.05e-05	0.000236	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1e-05	0.000226	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.89e-06	0.000223	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	9.82e-06	0.000221	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.77e-06	0.00022	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.26e-06	0.000209	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.22e-06	0.000208	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.21e-06	0.000207	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	9.12e-06	0.000205	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.05e-06	0.000204	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	8.5e-06	0.000191	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	8.32e-06	0.000187	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—ALB—chronic obstructive pulmonary disease	7.97e-06	0.000179	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—NOS3—chronic obstructive pulmonary disease	7.62e-06	0.000172	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.55e-06	0.00017	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.44e-06	0.000168	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.12e-06	0.00016	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	7.04e-06	0.000158	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.94e-06	0.000156	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.57e-06	0.000148	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	6.42e-06	0.000145	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.39e-06	0.000144	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.31e-06	0.000142	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—ALB—chronic obstructive pulmonary disease	6.3e-06	0.000142	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—NOS3—chronic obstructive pulmonary disease	6.02e-06	0.000136	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—ALB—chronic obstructive pulmonary disease	5.94e-06	0.000134	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.92e-06	0.000133	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.88e-06	0.000132	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—NOS3—chronic obstructive pulmonary disease	5.68e-06	0.000128	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.57e-06	0.000125	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.93e-06	0.000111	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.87e-06	0.00011	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.53e-06	0.000102	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	4.47e-06	0.000101	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.3e-06	9.68e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	4.27e-06	9.62e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	3.79e-06	8.52e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	3.62e-06	8.15e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2.92e-06	6.58e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.79e-06	6.29e-05	CbGpPWpGaD
